Physician profile
Gregory Byrd
NPI 1376619734
$17,535.82
in general payments reported to CMS, 2019-2025
41 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,058 · 2020: $370 · 2021: $887 · 2022: $523 · 2023: $9,113 · 2024: $3,048 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,480 · Education: $5,642 · Food and Beverage: $2,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,480.00 |
| Education | $5,641.91 |
| Food and Beverage | $2,575.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,047.82 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Janssen Biotech, INC. | $551.60 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $473.50 | 2020-2025 | Ams 700, Spaceoar Vue System - 10ml |
| Dendreon Pharmaceuticals LLC | $224.27 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $203.80 | 2019-2024 | Xtandi |
| Verity Pharmaceuticals INC. | $197.07 | 2021-2024 | Trelstar |
| Conmed Corporation | $177.76 | 2019-2024 | Airseal |
| Janssen Scientific Affairs, LLC | $168.49 | 2019 | |
| Abbvie INC. | $159.77 | 2019-2023 | Botox, Lupron Depot |
| Pfizer INC. | $146.34 | 2019-2025 | |
| Tolmar, INC. | $138.53 | 2025 | |
| Ferring Pharmaceuticals INC. | $138.03 | 2024-2025 | Adstiladrin |
| Olympus America INC. | $137.07 | 2022-2025 | Itind System, Bovie |
| Immunitybio, INC. | $124.09 | 2024 | |
| Amgen INC. | $122.39 | 2019-2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $111.87 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo Pharmaceuticals INC. | $110.18 | 2019-2021 | |
| Blue Earth Diagnostics | $98.72 | 2021-2023 | |
| Allergan, INC. | $94.76 | 2019-2022 | |
| Myovant Sciences INC. | $92.56 | 2021 | |
| Procept Biorobotics Corporation | $91.26 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $88.58 | 2020-2022 | |
| Siemens Medical Solutions USA, INC. | $88.25 | 2021-2023 | Truebeam |
| Antares Pharma, INC. | $83.66 | 2019-2021 | |
| Calyxo, INC. | $78.26 | 2024-2025 | Cvac Aspiration System |
| Clarus Therapeutics INC. | $74.70 | 2021 | |
| Axonics, INC. | $67.16 | 2023 | Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $65.00 | 2022 | |
| Neotract INC. | $64.28 | 2019 | |
| Travere Therapeutics, INC. | $55.97 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $47.66 | 2021-2025 | Lynparza, Keytruda |
| Coloplast Corp | $40.71 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $40.25 | 2024 | |
| Urovant Sciences INC | $32.27 | 2021-2022 | |
| Urogen Pharma, INC. | $27.61 | 2021 | |
| Medtronic, INC. | $17.48 | 2025 | Interstim |
| Teleflex LLC | $16.19 | 2023 | Urolift |
| Ambu INC. | $15.43 | 2025 | |
| Davol INC. | $11.31 | 2019 | |
| Sun Pharmaceutical Industries INC. | $11.17 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.